<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Regeneron Pharmaceuticals</title>
    <link>http://www.newstin.co.uk/uk/REGENERON_PHARMACEUTICALS</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Regeneron Pharmaceuticals - News</title>
      <link>http://www.newstin.co.uk/uk/REGENERON_PHARMACEUTICALS</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Sun, 08 Nov 2009 09:54:09 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/REGENERON_PHARMACEUTICALS</guid>
      <dc:date>2009-11-08T09:54:09Z</dc:date>
    </item>
    <item>
      <title>Regeneron Reports Third Quarter 2009 Financial and Operating Results</title>
      <link />
      <description />
      <pubDate>Tue, 03 Nov 2009 23:24:52 GMT</pubDate>
      <guid />
      <dc:date>2009-11-03T23:24:52Z</dc:date>
    </item>
    <item>
      <title>BUYINS.NET: CTL, REGN, ROCK, LZB, ALX, WSC Expected To Be Higher Leading Up To Next Earnings...</title>
      <link />
      <description />
      <pubDate>Fri, 30 Oct 2009 10:07:16 GMT</pubDate>
      <guid />
      <dc:date>2009-10-30T10:07:16Z</dc:date>
    </item>
    <item>
      <title>BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results</title>
      <link />
      <description />
      <pubDate>Thu, 29 Oct 2009 01:49:57 GMT</pubDate>
      <guid />
      <dc:date>2009-10-29T01:49:57Z</dc:date>
    </item>
    <item>
      <title>Regeneron Pharmaceuticals Inc-Therapeutic Competitors - research report released</title>
      <link />
      <description />
      <pubDate>Wed, 28 Oct 2009 10:37:05 GMT</pubDate>
      <guid />
      <dc:date>2009-10-28T10:37:05Z</dc:date>
    </item>
    <item>
      <title>UPDATE 3-Novartis says EU approves inflammatory disease drug</title>
      <link />
      <description />
      <pubDate>Wed, 28 Oct 2009 18:43:23 GMT</pubDate>
      <guid />
      <dc:date>2009-10-28T18:43:23Z</dc:date>
    </item>
    <item>
      <title>Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of...</title>
      <link />
      <description />
      <pubDate>Tue, 27 Oct 2009 20:19:22 GMT</pubDate>
      <guid />
      <dc:date>2009-10-27T20:19:22Z</dc:date>
    </item>
    <item>
      <title>Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference (PR...</title>
      <link />
      <description />
      <pubDate>Tue, 27 Oct 2009 13:39:46 GMT</pubDate>
      <guid />
      <dc:date>2009-10-27T13:39:46Z</dc:date>
    </item>
    <item>
      <title>ACR: Novel Gout Drug Cuts Flare Rate in Half (CME/CE)</title>
      <link />
      <description />
      <pubDate>Fri, 23 Oct 2009 14:03:58 GMT</pubDate>
      <guid />
      <dc:date>2009-10-23T14:03:58Z</dc:date>
    </item>
    <item>
      <title>Regeneron Pharmaceuticals (REGN) Bearish Technical Alert - Trend Down 8.8%</title>
      <link />
      <description />
      <pubDate>Thu, 15 Oct 2009 19:23:18 GMT</pubDate>
      <guid />
      <dc:date>2009-10-15T19:23:18Z</dc:date>
    </item>
  </channel>
</rss>

